| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | $4.1B |
| Cost of Revenue | $9.0B | $8.7B | $12.9B | $11.6B | $11.0B | $11.0B | $10.3B | $12.2B |
| Gross Profit | $3.0B | $2.8B | $3.5B | $3.3B | $3.0B | $2.6B | $2.5B | $2.8B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.1B | $2.1B | $2.4B | $2.4B | $2.4B | $2.1B | $2.1B | $2.2B |
| Operating Income | $0.9B | $0.2B | $1.1B | $0.9B | $0.7B | $0.0B | $0.1B | $0.2B |
| Net Income | $0.3B | $0.3B | $0.7B | $0.6B | $0.5B | $0.1B | $0.1B | $-0.0B |
| EPS (Basic) | $2.39 | $2.52 | $5.32 | $5.01 | $3.22 | $0.63 | $1.06 | $-0.26 |
| EPS (Diluted) | $2.38 | $2.51 | $5.30 | $4.98 | $3.20 | $0.62 | $1.04 | $-0.26 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.3B | $11.8B | $14.6B | $14.7B | $14.6B | $12.4B | $11.5B | $12.6B |
| Current Assets | $4.4B | $4.9B | $4.7B | $4.7B | $4.3B | $4.5B | $4.1B | $4.6B |
| Cash & Equivalents | $1.2B | $1.1B | $0.9B | $1.1B | $1.0B | $0.9B | $0.6B | $0.8B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $3.4B | $4.1B | $3.4B | $3.3B | $3.2B | $2.9B | $3.1B | $3.1B |
| Stockholders' Equity | $3.6B | $4.5B | $6.5B | $6.1B | $5.9B | $5.8B | $5.7B | $5.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $1.1B | $1.0B | $0.5B | $0.7B | $0.8B | $-0.4B | $0.5B |
| Investing Cash Flow | $-0.1B | $-0.1B | $-0.1B | $-0.5B | $-1.4B | $-0.4B | $2.2B | $-1.6B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.5B | $-0.8B | $-1.1B | $0.3B | $0.8B | $-0.2B | $-2.0B | $1.1B |